![](/img/cover-not-exists.png)
A phase II study of atezolizumab in combination with bevacizumab in patients with recurrent, persistent or metastatic cervical cancer
Friedman, C.F., Snyder, A., Sharon, E., De Meritens, A. Buckley, Cantrell, L.A., Corr, B.R., Konner, J., Konstantinopoulos, P.A., Soldan, K., Aghajanian, C.A., Zamarin, D.Volume:
154
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2019.04.045
Date:
June, 2019
File:
PDF, 286 KB
english, 2019